Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.
about
Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factorsExport of microRNAs: A Bridge between Breast Carcinoma and Their Neighboring CellsBasic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral OncologyOral complications in hematopoietic stem cell recipients: the role of inflammationA Randomized Placebo- Controlled Double Blind Clinical Trial of Quercetin in the Prevention and Treatment of Chemotherapy-Induced Oral Mucositis.Dusquetide: Reduction in oral mucositis associated with enduring ancillary benefits in tumor resolution and decreased mortality in head and neck cancer patients.MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.Adverse event management of oral mucositis in patients with breast cancerVarious forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.The role of Smad7 in oral mucositis.Nucleotide excision repair pathway assessment in DNA exposed to low-intensity red and infrared lasers.Comprehensive Assessment of Host Responses to 5-Fluorouracil-Induced Oral Mucositis through Transcriptomic AnalysisMouth-rinses for the prevention of chemotherapy induced oral mucositis in children: a systematic review.Expression of salivary biomarkers in patients with oral mucositis: evaluation by SELDI-TOF/MS.Preventive effects of amino-acid-rich elemental diet Elental® on chemotherapy-induced oral mucositis in patients with colorectal cancer: a prospective pilot study.Repairing effects of interleukin 11 (IL-11) towards high dose methotrexate-induced rat small intestinal mucositis and its impacts on T-lymphoblastic leukemia cell lineRepairing effects of interleukin 11 (IL-11) towards high dose methotrexate-induced rat small intestinal mucositis and its impacts on T-lymphoblastic leukemia cell line.Prevention and treatment of oral mucositis in patients receiving chemotherapyGuideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation.Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients.SAMITAL®: a new botanical drug for the treatment of mucositis induced by oncological therapies.Oral mucosal injury caused by cancer therapies: current management and new frontiers in research.New pharmacotherapy options for chemotherapy-induced alimentary mucositis.Radioprotection of normal tissue cells.Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation.Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.8-prenylnaringenin and tamoxifen inhibit the shedding of irradiated epithelial cells and increase the latency period of radiation-induced oral mucositis : cell culture and murine model.Palifermin and Chlorhexidine Mouthwashes in Prevention of Chemotherapy-Induced Mucositis in Children with Acute Lymphocytic Leukemia: a Randomized Controlled Trial.The Role of Nerve Growth Factor (NGF) and Its Precursor Forms in Oral Wound HealingEffect of SAMITAL® in the treatment of chemotherapy-induced mucositis in adult oncohematological patients.Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis.TNF as marker of oral candidiasis, HSV infection, and mucositis onset during chemotherapy in leukemia patients.A hyaluronic acid-based compound inhibits fibroblast senescence induced by oxidative stress in vitro and prevents oral mucositis in vivo.Evaluation of efficacy of Caphosol in prevention and alleviation of acute side effects in patients treated with radiotherapy for head and neck cancers.Oral mucositis in cancer treatment: Natural history, prevention and treatment.Treatment of chemically induced oral ulcer using adipose-derived mesenchymal stem cell sheet.Personalized medicine: predicting the risk of complications of cancer therapy.The MASCC/ISOO mucositis guidelines: dissemination and clinical impact.Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors.Radioprotective Effects of Dermatan Sulfate in a Preclinical Model of Oral Mucositis-Targeting Inflammation, Hypoxia and Junction Proteins without Stimulating Proliferation.
P2860
Q24187456-F26531D4-64F6-491B-85BA-82A362276F41Q26744487-43213BC5-B406-458F-AA90-ACC9F5F99AECQ27026718-015248C1-19E3-4BA2-92F1-6BABE90B43BBQ27027650-EBB4F8FF-8742-42D6-A7F3-DD6166D4C39CQ33667061-E996D7D6-764F-461A-B6DF-48A4D36F0446Q33796590-3D3AF9B9-548F-41E8-BAAD-4291D1956C28Q34180792-BCC46A80-86C8-4DB9-968C-375D33C6B59FQ34403510-8BC2B37F-0403-4EAB-8C54-3BB0066D7356Q35022269-D35BED71-BC79-4FA4-8C07-9E8E93244A39Q35143104-3FFEC236-C572-41DB-B643-426373ED8688Q35691843-73B7AF79-4935-4FD5-B3B9-A8DAD1DD24A7Q35743724-8601D3D8-DD93-4D13-8D00-0E3775F38043Q35763375-A28D0BA7-81D1-4C25-B175-E03D27B50BEAQ35854455-854CE063-AAFE-47B5-A9CF-AAB8E17D8359Q36400324-962A5CAF-0534-49FC-9D85-33BBB3CC0775Q37231108-A4309774-B527-463F-B624-CD126A0A7081Q37306930-313AD3E2-22B9-44DB-82BB-7A6C77462F5CQ37605224-AB2144D9-A2A7-45EF-95C9-5403F079E9A6Q37683584-B9A92C5E-745F-43A7-8DE6-ABA16B3C3384Q38125395-35FB9055-2F3E-4DD6-8C78-0C6054F9C18DQ38155203-89FE1E11-0BAA-402F-9D5B-446F2D66746AQ38164809-6E2EF31D-578D-48E1-BB08-5FC6DB8D7C28Q38175515-A48EFCD6-FC22-4C33-943B-121F6917752DQ38196712-9E82C068-13CC-4F2D-8917-BF6D9A348216Q38384344-8870544C-1905-4E6D-8A40-D424BCAA341BQ38589005-62CCE85E-1BB1-488E-B736-94BD80D27C1CQ38937116-C14BC0E8-D319-4D23-93DF-47A9FD8F97D9Q39109668-AD0E9DF1-932D-4390-8160-97EB9F4A7AB7Q39139211-6955B06B-7C98-4FF1-AAA0-860C03F4E32BQ39326895-CD53E8D4-C86A-4E8E-9586-A6C0CC069FC3Q39379337-4B7B635F-6F71-4DB9-B33A-5BBEE292081EQ40245483-3EE9A570-D942-439B-8386-5A973585DBF9Q41654736-46E0CE0B-1FC4-4463-A9CD-4DA8A4DA0D20Q42063541-97DC8DD3-ADA5-46B5-956B-A9E9E1E5DA3AQ42332590-9C9019C5-B796-4A80-94D9-E65E612572E7Q42501259-79DB153F-A9C3-4508-A198-25E5C2260183Q44183934-33DD3D12-452D-4F4E-8A3B-FC99041DCD43Q46797014-4A3547EF-1C2A-4E27-B02A-C0FBD2727938Q47404146-D137FFBF-8189-43A6-94D3-A46246BC6FDCQ55656164-3F10FF07-F018-4023-B407-6BD32F91A319
P2860
Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Systematic review of cytokines ...... mucositis in cancer patients.
@en
type
label
Systematic review of cytokines ...... mucositis in cancer patients.
@en
prefLabel
Systematic review of cytokines ...... mucositis in cancer patients.
@en
P2093
P2860
P1476
Systematic review of cytokines ...... l mucositis in cancer patients
@en
P2093
Bo G Pettersson
Erich Gerber
Fred K L Spijkervet
Hele Everaus
Inger von Bültzingslöwen
Jesùs Garcia Gomez
Joel B Epstein
Judith E Raber-Durlacher
Mucositis Study Group of the M ...... of Oral Oncology (MASCC/ISOO)
Rajesh V Lalla
P2860
P2888
P304
P356
10.1007/S00520-012-1594-5
P577
2012-09-18T00:00:00Z